Records containing: Thyroid Eye Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2023-11-14Local Betamethasone Versus Triamcinolone Injection in Management of Thyroid-Related Upper Lid Retraction With and Without Proptosis
-
CLINICAL_TRIALS study record update · 2023-09-28The Effect of a New Antioxidant Combination (ASTED) on Mild Thyroid Eye Disease, a Placebo Controlled Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2023-02-16Development of an Artificial Intelligence Solution to Evaluate Clinical Activity of Thyroid Associated Orbitopathy Using Periocular Selfie Images Taken by Smartphones in Patients With Thyroid Dysfunction
-
CLINICAL_TRIALS study record update · 2022-11-25Customized Modified Multiple Orbital Wall Decompression With Fat Removal for Sight-threatening Graves's Ophthalmopathy : a Retrospective Cohort Study
-
CLINICAL_TRIALS study record update · 2022-06-23Treatment With Tamsulosin for Upper Eyelid Retraction Related to Thyroid Eye Disease.
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2022-02-16Anterior Segment Optical Coherence Tomography Study of the Tear Film and Cornea in Thyroid Eye Diseases.
-
CLINICAL_TRIALS study record update · 2022-01-10The Effect of a New Antioxidant Combination (ASTED) on Moderate to Severe Thyroid Eye Disease, a Double Blind Placebo Controlled Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2021-10-04Phase IV Study of Hyaluronic Acid Gels for Upper Lid Retraction in Active Stage Thyroid Eye Disease
-
CLINICAL_TRIALS study record update · 2021-07-19Multicenter, Safety and Efficacy, Open-Label Extension Study Evaluating Teprotumumab (HZN-001) Treatment in Subjects With Thyroid Eye Disease
-
CLINICAL_TRIALS study record update · 2020-07-31An Open Label Trial of Celecoxib in the Treatment of Mild Thyroid Eye Disease
-
CLINICAL_TRIALS study record update · 2020-06-16Corneal Tomographic Analysis Among Patients With Thyroid Gland Dysfunction.
-
CLINICAL_TRIALS study record update · 2020-03-10A Phase 3, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, Multicenter Study Evaluating Teprotumumab (HZN-001) Treatment in Subjects With Active Thyroid Eye Disease
-
CLINICAL_TRIALS study record update · 2019-11-18B-cell Depletion Therapy With Rituximab for Thyroid Eye Disease
-
CLINICAL_TRIALS study record update · 2019-09-20The Therapeutic Effect of Dysthyroid Optic Neuropathy
-
CLINICAL_TRIALS study record update · 2018-05-15The Secondary Beneficial Effects of Prostaglandin Analog Treatment in Thyroid Eye Disease Patients.
-
CLINICAL_TRIALS study record update · 2017-04-06Evaluation of the Disappearance of Graves' Orbitopathy in the Long Term
-
CLINICAL_TRIALS study record update · 2016-01-20Clinical Trial Phase III, Parallel Group, Randomized, Placebo-controlled, Double-blind, Multicenter Study to Evaluate the Efficacy and Safety of Tocilizumab Administration in Patients With Moderate-to-severe or Sight-threatening Graves' Ophthalmopathy (GO), That Had Not Responded Adequately to Treatment With Intravenous Corticoid Pulses.
-
CLINICAL_TRIALS study record update · 2015-03-02The Effects of Orbital Decompression Surgery on Intraocular Pressure Patterns in Patient With Thyroid Eye Disease Undergoing 24 Hour Continuous IOP Monitoring With the SENSIMED Triggerfish®